We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
KOPRAN.NSE

Price
190.08
Stock movement up
+14.85 (8.47%)
Company name
Kopran Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
9.17B
Ent value
11.65B
Price/Sales
1.44
Price/Book
1.84
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
17.34
Forward P/E
-
PEG
-
EPS growth
13.69%
1 year return
-32.39%
3 year return
-13.50%
5 year return
56.19%
10 year return
14.25%
Last updated: 2025-04-15

DIVIDENDS

KOPRAN.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E17.34
Price to OCF140.42
Price to FCF140.42
Price to EBITDA35.26
EV to EBITDA44.81

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.44
Price to Book1.84
EV to Sales1.83

FINANCIALS

Per share

Loading...
Per share data
Current share count48.25M
EPS (TTM)10.96
FCF per share (TTM)1.35

Income statement

Loading...
Income statement data
Revenue (TTM)6.36B
Gross profit (TTM)2.09B
Operating income (TTM)810.31M
Net income (TTM)528.93M
EPS (TTM)10.96
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)32.78%
Operating margin (TTM)12.74%
Profit margin (TTM)8.32%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash18.84M
Net receivables0.00
Total current assets4.34B
Goodwill58.00K
Intangible assets235.53M
Property, plant and equipment0.00
Total assets7.47B
Accounts payable829.18M
Short/Current long term debt1.24B
Total current liabilities2.15B
Total liabilities2.50B
Shareholder's equity4.97B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)65.31M
Capital expenditures (TTM)0.00
Free cash flow (TTM)65.31M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity10.64%
Return on Assets7.08%
Return on Invested Capital8.75%
Cash Return on Invested Capital1.08%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open182.99
Daily high192.48
Daily low182.99
Daily Volume562K
All-time high490.00
1y analyst estimate74.00
Beta0.58
EPS (TTM)10.96
Dividend per share-
Ex-div date2 Sep 2024
Next earnings date-

Downside potential

Loading...
Downside potential data
KOPRAN.NSES&P500
Current price drop from All-time high-61.21%-12.89%
Highest price drop-98.61%-56.47%
Date of highest drop12 Mar 20099 Mar 2009
Avg drop from high-81.07%-11.07%
Avg time to new high7453 days12 days
Max time to new high7452 days1805 days
COMPANY DETAILS
KOPRAN.NSE (Kopran Limited) company logo
Marketcap
9.17B
Marketcap category
Mid-cap
Description
Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
Employees
842
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found